Evidence map›Paper›PMID 24648491›Full record

ArticleMolecular biology of the cell2014

Nucleophosmin modulates stability, activity, and nucleolar accumulation of base excision repair proteins.

Mattia Poletto, Lisa Lirussi, David M Wilson, Gianluca Tell

Open access · greenAbstract read
In one paragraph

Article in Molecular biology of the cell, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 74 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Targeting and Monitoring Acute Myeloid Leukaemia with Nucleophosmin-1 (International journal of molecular sciences · 2023
    Review
  15. Article
  16. Frequency of Nucleophosmin 1 Expression by Immunohistochemistry in Acute Myeloid Leukemia.Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion · 2022
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Mattia PolettoDepartment of Medical and Biological Sciences, University of Udine, Udine 33100, Italy.
Lisa LirussiDepartment of Medical and Biological Sciences, University of Udine, Udine 33100, Italy.
David M WilsonLaboratory of Molecular Gerontology, National Institute on Aging, Intramural Research Program, National Institutes of Health, Baltimore, MD 21224.
Gianluca TellDepartment of Medical and Biological Sciences, University of Udine, Udine 33100, Italy gianluca.tell@uniud.it.
University of Udine · ITNational Institutes of Health · US

Funding

Repair Mechanisms For Oxidative DNA DamageZIAAG000743 · NIA · NATIONAL INSTITUTE ON AGING · PI WILSON, DAVID · 2009 to 2015
$2.5M
Intramural NIH HHS
6 · The paper itself

Abstract

Nucleophosmin (NPM1) is a multifunctional protein that controls cell growth and genome stability via a mechanism that involves nucleolar-cytoplasmic shuttling. It is clear that NPM1 also contributes to the DNA damage response, yet its exact function is poorly understood. We recently linked NPM1 expression to the functional activation of the major abasic endonuclease in mammalian base excision repair (BER), apurinic/apyrimidinic endonuclease 1 (APE1). Here we unveil a novel role for NPM1 as a modulator of the whole BER pathway by 1) controlling BER protein levels, 2) regulating total BER capacity, and 3) modulating the nucleolar localization of several BER enzymes. We find that cell treatment with the genotoxin cisplatin leads to concurrent relocalization of NPM1 and BER components from nucleoli to the nucleoplasm, and cellular experiments targeting APE1 suggest a role for the redistribution of nucleolar BER factors in determining cisplatin toxicity. Finally, based on the use of APE1 as a representative protein of the BER pathway, our data suggest a function for BER proteins in the regulation of ribogenesis.

Indexed as

AnimalsCell NucleolusCisplatinCross-Linking ReagentsDNA-(Apurinic or Apyrimidinic Site) LyaseDNA DamageDNA Ligase ATPDNA LigasesDNA RepairDoxycyclineFlap EndonucleasesHeLa CellsHumansMiceNuclear ProteinsNucleophosminApex1 protein, mouseCisplatinCross-Linking ReagentsDNA-(Apurinic or Apyrimidinic Site) LyaseDNA Ligase ATPDNA LigasesDoxycyclineFen1 protein, mouseFlap EndonucleasesNPM1 protein, humanNpm1 protein, mouseNuclear ProteinsNucleophosminRNA, Small InterferingTumor Suppressor Protein p53

Identifiers

PMID24648491
PMCPMC4019495
OpenAlexW2144408606

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.